Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review
Background:. Lymphovenous anastomosis (LVA) is an accepted microsurgical treatment for lymphedema of the upper extremity (UE). This study summarizes and analyzes recent data on the outcomes associated with LVA for UE lymphedema at varying degrees of severity. Methods:. A literature search was conduc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-08-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003770 |
id |
doaj-eebfbde73c344a07871b60a0ee10fdf8 |
---|---|
record_format |
Article |
spelling |
doaj-eebfbde73c344a07871b60a0ee10fdf82021-09-28T10:19:02ZengWolters KluwerPlastic and Reconstructive Surgery, Global Open2169-75742021-08-0198e377010.1097/GOX.0000000000003770202108000-00054Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic ReviewNikita Gupta, BS0Erik M. Verhey, BS1Ricardo A. Torres-Guzman, MD2Francisco R. Avila, MD3Antonio Jorge Forte, MD, PhD4Alanna M. Rebecca, MD, MBA5Chad M. Teven, MD6From the * Mayo Clinic Alix School of Medicine, Scottsdale, Ariz.† University of Notre Dame, Department of Biological Sciences, Notre Dame, Ind.‡ Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Jacksonville, Fla.‡ Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Jacksonville, Fla.‡ Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Jacksonville, Fla.‡ Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Jacksonville, Fla.§ Division of Plastic and Reconstructive Surgery, Department of Surgery, Mayo Clinic, Phoenix, Ariz.Background:. Lymphovenous anastomosis (LVA) is an accepted microsurgical treatment for lymphedema of the upper extremity (UE). This study summarizes and analyzes recent data on the outcomes associated with LVA for UE lymphedema at varying degrees of severity. Methods:. A literature search was conducted in the PubMed database to extract articles published through June 19, 2020. Studies reporting data on postoperative improvement in limb circumference/volume or subjective improvement in quality of life for patients with primary or secondary lymphedema of the UE were included. Extracted data consisted of demographic data, number of patients and upper limbs, duration of symptoms before LVA, surgical technique, follow-up, and objective and subjective outcomes. Results:. A total of 92 articles were identified, of which 16 studies were eligible for final inclusion comprising a total of 349 patients and 244 upper limbs. The average age of patients ranged from 38.4 to 64 years. The duration of lymphedema before LVA ranged from 9 months to 7 years. The mean length of follow-up ranged from 6 months to 8 years. Fourteen studies reported an objective improvement in limb circumference or volume measurements following LVA, ranging from 0% to 100%. Patients included had varying severity of lymphedema, ranging from Campisi stage I to IV. The maximal improvement in objective measurements was found in patients with lower stage lymphedema. Conclusion:. LVA is a safe, effective technique for the treatment of UE lymphedema refractory to decompressive treatment. Results of LVA indicate greater efficacy in earlier stages of lymphedema before advanced lymphatic sclerosis.http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003770 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nikita Gupta, BS Erik M. Verhey, BS Ricardo A. Torres-Guzman, MD Francisco R. Avila, MD Antonio Jorge Forte, MD, PhD Alanna M. Rebecca, MD, MBA Chad M. Teven, MD |
spellingShingle |
Nikita Gupta, BS Erik M. Verhey, BS Ricardo A. Torres-Guzman, MD Francisco R. Avila, MD Antonio Jorge Forte, MD, PhD Alanna M. Rebecca, MD, MBA Chad M. Teven, MD Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review Plastic and Reconstructive Surgery, Global Open |
author_facet |
Nikita Gupta, BS Erik M. Verhey, BS Ricardo A. Torres-Guzman, MD Francisco R. Avila, MD Antonio Jorge Forte, MD, PhD Alanna M. Rebecca, MD, MBA Chad M. Teven, MD |
author_sort |
Nikita Gupta, BS |
title |
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review |
title_short |
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review |
title_full |
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review |
title_fullStr |
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review |
title_full_unstemmed |
Outcomes of Lymphovenous Anastomosis for Upper Extremity Lymphedema: A Systematic Review |
title_sort |
outcomes of lymphovenous anastomosis for upper extremity lymphedema: a systematic review |
publisher |
Wolters Kluwer |
series |
Plastic and Reconstructive Surgery, Global Open |
issn |
2169-7574 |
publishDate |
2021-08-01 |
description |
Background:. Lymphovenous anastomosis (LVA) is an accepted microsurgical treatment for lymphedema of the upper extremity (UE). This study summarizes and analyzes recent data on the outcomes associated with LVA for UE lymphedema at varying degrees of severity.
Methods:. A literature search was conducted in the PubMed database to extract articles published through June 19, 2020. Studies reporting data on postoperative improvement in limb circumference/volume or subjective improvement in quality of life for patients with primary or secondary lymphedema of the UE were included. Extracted data consisted of demographic data, number of patients and upper limbs, duration of symptoms before LVA, surgical technique, follow-up, and objective and subjective outcomes.
Results:. A total of 92 articles were identified, of which 16 studies were eligible for final inclusion comprising a total of 349 patients and 244 upper limbs. The average age of patients ranged from 38.4 to 64 years. The duration of lymphedema before LVA ranged from 9 months to 7 years. The mean length of follow-up ranged from 6 months to 8 years. Fourteen studies reported an objective improvement in limb circumference or volume measurements following LVA, ranging from 0% to 100%. Patients included had varying severity of lymphedema, ranging from Campisi stage I to IV. The maximal improvement in objective measurements was found in patients with lower stage lymphedema.
Conclusion:. LVA is a safe, effective technique for the treatment of UE lymphedema refractory to decompressive treatment. Results of LVA indicate greater efficacy in earlier stages of lymphedema before advanced lymphatic sclerosis. |
url |
http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000003770 |
work_keys_str_mv |
AT nikitaguptabs outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT erikmverheybs outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT ricardoatorresguzmanmd outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT franciscoravilamd outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT antoniojorgefortemdphd outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT alannamrebeccamdmba outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview AT chadmtevenmd outcomesoflymphovenousanastomosisforupperextremitylymphedemaasystematicreview |
_version_ |
1716866292270497792 |